The DELTA HEALTH GROUP is a global healthcare conglomerate focused on providing a comprehensive portfolio of innovative clinical drug development expertise, a worldwide network of dedicated clinical trial investigative sites, international telemedicine, global destination medical services and an innovative medical products division. We have been assisting partners in the healthcare sector optimize and develop reformulated drug products, new chemical entities, biologics, vaccines and medical devices that aim to offer advanced therapies and an improvement to available patient care. We operate exclusive, high-performance, international clinical trial investigative sites specializing in the conduct of Phase 2 and Phase 3 drug development clinical trials according to ICH Good Clinical Practice Guidelines. The DELTA HEALTH GROUP offers telemedicine services with our top-class Board Certified Medical Specialists based in the United States, Canada and the United Kingdom for patients from around the world. DELTA also provides GLOBAL DESTINATION MEDICAL SERVICES representing the largest hospital chain in Turkiye offering state-of-the-art medical and surgical services for patients from around the world. DELTA HEALTH is accepting patients for Specialist Evaluation from assigned geographic regions. The DELTA HEALTH GROUP Global Products Division operates as an international source of innovative healthcare product lines.
